These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20511173)

  • 1. Health trends.
    Nwachukwu U
    Consult Pharm; 2010 Apr; 25(4):199-202. PubMed ID: 20511173
    [No Abstract]   [Full Text] [Related]  

  • 2. Apixaban to prevent venous thromboembolism after knee replacement.
    Fareed J; Hull R
    Lancet; 2010 Mar; 375(9717):779-80. PubMed ID: 20206758
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries for patients. Salsalate for type 2 diabetes mellitus.
    Ann Intern Med; 2013 Jul; 159(1):I-32. PubMed ID: 23817718
    [No Abstract]   [Full Text] [Related]  

  • 4. RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients.
    Kachnic LA; Pugh SL; Tai P; Smith M; Gore E; Shah AB; Martin AG; Kim HE; Nabid A; Lawton CA
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):382-6. PubMed ID: 24080992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
    Bays HE; Brinton EA; Triscari J; Chen E; Maccubbin D; MacLean AA; Gibson KL; Ruck RA; Johnson-Levonas AO; O'Neill EA; Mitchel YB
    Vasc Health Risk Manag; 2015; 11():165-72. PubMed ID: 25750540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
    Raskob GE; Gallus AS; Pineo GF; Chen D; Ramirez LM; Wright RT; Lassen MR
    J Bone Joint Surg Br; 2012 Feb; 94(2):257-64. PubMed ID: 22323697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results.
    Takahashi S; Iwase T; Kohno N; Ishikawa T; Taguchi T; Takahashi M; Horiguchi J; Nakamura S; Hozumi Y; Fukunaga M; Noguchi S
    Breast Cancer Res Treat; 2012 Jun; 133(2):685-93. PubMed ID: 22307266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999-2010.
    Wong HK; Ong KL; Cheung CL; Cheung BM
    Ann Epidemiol; 2014 Jul; 24(7):516-21.e1. PubMed ID: 24935464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence.
    Kaul U; Parmar D; Manjunath K; Shah M; Parmar K; Patil KP; Jaiswal A
    Cardiovasc Diabetol; 2019 Jun; 18(1):80. PubMed ID: 31208414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
    Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose rosiglitazone in patients with type 2 diabetes mellitus requiring insulin therapy.
    Lopez CA; Kanna B
    Arch Intern Med; 2008 Mar; 168(5):548. PubMed ID: 18332304
    [No Abstract]   [Full Text] [Related]  

  • 12. Zoledronic acid and secondary prevention of fractures.
    Calis KA; Pucino F
    N Engl J Med; 2007 Nov; 357(18):1861-2. PubMed ID: 17878150
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
    Coleman R; Cameron D; Dodwell D; Bell R; Wilson C; Rathbone E; Keane M; Gil M; Burkinshaw R; Grieve R; Barrett-Lee P; Ritchie D; Liversedge V; Hinsley S; Marshall H;
    Lancet Oncol; 2014 Aug; 15(9):997-1006. PubMed ID: 25035292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical oncology: Zoledronic acid for breast cancer therapy-induced bone loss.
    Amir E; Ocaña A; Seruga B; Josse R; Clemons M
    Nat Rev Clin Oncol; 2010 Apr; 7(4):187-8. PubMed ID: 20354540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Zoledronic acid for preventing fractures].
    Traut V
    Internist (Berl); 2008 Aug; 49(8):1002; author reply 1002. PubMed ID: 18545977
    [No Abstract]   [Full Text] [Related]  

  • 16. Zoledronic acid and clinical fractures and mortality after hip fracture.
    Lyles KW; Colón-Emeric CS; Magaziner JS; Adachi JD; Pieper CF; Mautalen C; Hyldstrup L; Recknor C; Nordsletten L; Moore KA; Lavecchia C; Zhang J; Mesenbrink P; Hodgson PK; Abrams K; Orloff JJ; Horowitz Z; Eriksen EF; Boonen S;
    N Engl J Med; 2007 Nov; 357(18):1799-809. PubMed ID: 17878149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study.
    Hadji P; Kauka A; Ziller M; Birkholz K; Baier M; Muth M; Bauer M
    Osteoporos Int; 2014 Apr; 25(4):1369-78. PubMed ID: 24504100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials.
    Huang J; Cao Y; Liao C; Wu L; Gao F
    Thromb Haemost; 2011 Feb; 105(2):245-53. PubMed ID: 20941455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial.
    Westin JR; Thompson MA; Cataldo VD; Fayad LE; Fowler N; Fanale MA; Neelapu S; Samaniego F; Romaguera J; Shah J; McLaughlin P; Pro B; Kwak LW; Sanjorjo P; Murphy WA; Jimenez C; Toth B; Dong W; Hagemeister FB
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):99-105. PubMed ID: 23276888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
    Lassen MR; Raskob GE; Gallus A; Pineo G; Chen D; Hornick P;
    Lancet; 2010 Mar; 375(9717):807-15. PubMed ID: 20206776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.